These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6944380)

  • 1. Analysis of HLA-DR antigens by using monoclonal antibodies: recognition of conformational differences in biosynthetic intermediates.
    Shackelford DA; Lampson LA; Strominger JL
    J Immunol; 1981 Oct; 127(4):1403-10. PubMed ID: 6944380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation of three class II antigens from a homozygous human B cell line.
    Shackelford DA; Lampson LA; Strominger JL
    J Immunol; 1983 Jan; 130(1):289-96. PubMed ID: 6600185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DR epitope region definition by use of monoclonal antibody probes.
    Grumet FC; Charron DJ; Fendly BM; Levy R; Ness DB
    J Immunol; 1980 Dec; 125(6):2785-9. PubMed ID: 6159421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple HLA-DR antigens: detection with monoclonal antibodies and translation in vitro.
    Finn OJ; Levy R
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2658-62. PubMed ID: 6979750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR antigens of autologous melanoma and B lymphoblastoid cell lines: differences in glycosylation but not protein structure.
    Alexander S; Hubbard SC; Strominger JL
    J Immunol; 1984 Jul; 133(1):315-20. PubMed ID: 6609984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
    Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
    J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ia molecular localization of the DRw52 allodeterminant and the DRw52-like determinants defined by monoclonal antibodies.
    Karr RW; Lipman LK; Alber C; Koning F; Goeken NE
    J Immunol; 1985 Oct; 135(4):2642-6. PubMed ID: 2411807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two populations of Ia-like molecules on a human B cell line.
    Lampson LA; Levy R
    J Immunol; 1980 Jul; 125(1):293-9. PubMed ID: 6966655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic heterogeneity of human colorectal cancer cell lines analyzed by a panel of monoclonal antibodies. I. Heterogeneous expression of Ia-like and HLA-like antigenic determinants.
    MacLean GD; Seehafer J; Shaw AR; Kieran MW; Longenecker BM
    J Natl Cancer Inst; 1982 Aug; 69(2):357-64. PubMed ID: 6180206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the MT3 molecule from HLA-DR4, 7, and w9 homozygous cell lines.
    Mukai R; Suzuki M; Yabe T; Hamaguchi H; Maeda H
    J Immunol; 1984 Dec; 133(6):3211-9. PubMed ID: 6436378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactions between mouse Ia and human HLA-D/DR antigens analyzed with monoclonal alloantibodies.
    Pierres M; Rebouah JP; Kourilsky FM; Dosseto M; Mercier P; Mawas C; Malissen B
    J Immunol; 1981 Jun; 126(6):2424-9. PubMed ID: 6785353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the biosynthesis of HLA-DR glycoproteins in human malignant melanoma cell lines.
    Lloyd KO; Ng J; Dippold WG
    J Immunol; 1981 Jun; 126(6):2408-13. PubMed ID: 6785352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the oligosaccharides on the HLA-DR and DC1 B cell antigens.
    Shackelford DA; Strominger JL
    J Immunol; 1983 Jan; 130(1):274-82. PubMed ID: 6600184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Two-dimensional gel analyses of HLA-D region antigens by the use of monoclonal antibodies].
    Takenouchi T
    Hokkaido Igaku Zasshi; 1983 May; 58(3):279-91. PubMed ID: 6194092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
    Maeda H; Hirata R
    J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of monomorphic determinants on DR molecules of HLA class II antigens.
    Poláková K; Karpatová M
    Neoplasma; 1990; 37(3):239-51. PubMed ID: 1695326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope mapping of an HLA-DR-specific monoclonal antibody produced by using human-mouse transfectant cells.
    Madrigal JA; Ikeda H; Marsh SG; Heyes JM; Kennedy LJ; Trowsdale J; Bodmer JG
    J Immunol; 1989 Dec; 143(12):4084-9. PubMed ID: 2480386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of antigen recognized by the monoclonal antibody (4F2): different molecular forms on human T and B lymphoblastoid cell lines.
    Hemler ME; Strominger JL
    J Immunol; 1982 Aug; 129(2):623-8. PubMed ID: 6177771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complexity of HLA-DS molecules. A homozygous cell line expresses multiple HLA-DS alpha chains.
    Karr RW; Alber C; Goyert SM; Silver J; Duquesnoy RJ
    J Exp Med; 1984 May; 159(5):1512-31. PubMed ID: 6425448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-A,B antigens Ia-like antigens, and tumor-associated antigens on prostate carcinoma cell lines: serologic and immunochemical analysis with monoclonal antibodies.
    Ng AK; Pellegrino MA; Imai K; Ferrone S
    J Immunol; 1981 Aug; 127(2):443-7. PubMed ID: 6788840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.